Quantcast

Latest Gross pathology Stories

2011-02-15 05:00:00

PALO ALTO, Calif., Feb. 15, 2011 /PRNewswire/ -- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna(TM) Aneurysm Embolization System (AES) received CE Mark for the treatment of patients with brain aneurysms. The Luna AES is designed to be a single-deployment, easy-to-use system for the treatment of brain aneurysms both pre- and post-rupture. "Brain aneurysm treatment...

2011-01-25 12:48:52

Foregut duplication cyst of the stomach is rare. Foregut duplications may or may not communicate with the gastrointestinal tract, and are usually diagnosed at a young age. There have been relatively few case reports describing this entity. Adenocarcinoma has been reported in four cases of gastric duplication cyst, but not in cysts that have a ciliated epithelium. Controversy exists concerning the embryological origin of these anomalies. A research article to be published on January 7, 2011 in...

2011-01-16 12:26:00

LOS ANGELES, Jan. 16, 2011 /PRNewswire/ -- Decadent Publishing announces the gathering of faery tales from nine celebrated authors in time for debut at the RT BOOKlover's Convention in Los Angeles, California on April 6-10th. Author royalties from the book will go to help defray the medical expenses of fellow author and RT Faery Court member, Tina Gerow, incurred following surgery for neurological symptoms related to a rare condition known as Arteriovenous Malformation. Twice Upon a Time...

2010-12-15 06:00:00

WALTHAM, Mass., Dec. 15, 2010 /PRNewswire/ -- Repligen Corporation (Nasdaq: RGEN) today announced that the Company has received $1,400,000 in research funding from the Muscular Dystrophy Association ("MDA") to support the ongoing development of RG3039 for Spinal Muscular Atrophy ("SMA"). RG3039, our lead compound, is an inhibitor of an RNA processing enzyme which targets increased production of SMN, a protein of deficient levels in patients with SMA. The goal of this grant is to support...

2010-12-02 21:34:47

Botulinum toxin A creates muscle weakness and atrophy following long term use A new study by researchers at the Faculty of Kinesiology, University of Calgary, is raising questions about the therapeutic use of botulinum toxin A. The study found that animals injected with Clostridium Botulinum type A neurotoxin complex (BOTOX, Allergan, Inc., Toronto, Ontario, Canada) experienced muscle weakness in muscles throughout the body, even though they were far removed from the injection site. The study...

2010-11-07 00:16:45

HCA Gulf Coast Division and The Joe Niekro Foundation present the second annual "Knuckle Ball"”A Pitch for Life" on Saturday, November 13th at Minute Maid Park. The event benefits The Joe Niekro Foundation funding education about brain aneurysms, aneurysm research and support for aneurysm patients and their families. Houston, TX (Vocus) November 4, 2010     HCA Gulf Coast Division and The Joe Niekro Foundation present the second annual "Knuckle Ball"”A Pitch...

2010-10-25 07:00:00

PALO ALTO, Calif., Oct. 25 /PRNewswire/ -- Nfocus Neuromedical Inc., an innovative medical device company focused on the next generation treatment for brain aneurysms, today announced the appointment of Eric Milledge to Chairman and CEO effective immediately. Milledge has served as the company's Chairman of the Board since April 2009. Former CEO, Martin Dieck, will assume the role of President and COO. Prior to joining Nfocus' Board, Milledge most recently served as Company Group...

2010-09-20 22:07:28

Delayed hepatic arterial hemorrhage after pancreaticoduodenectomy (PD) is not a common but a fatal complication, occurring in 7% of all patients. Its ideal management remains unclear and controversial. A research article published on August 7, 2010 in the World Journal of Gastroenterology addresses this question. The authors reported the clinical outcome of 9 patients with life-threatening hemorrhage from a ruptured hepatic artery pseudoaneurysm after PD after treatment with a new...

2010-08-03 09:00:00

TUSTIN, Calif., Aug. 3 /PRNewswire/ -- MicroVention, Inc., a leading developer, manufacturer and marketer of interventional neurovascular devices, announced today that the final 18-month follow-up data in an international study showed that its innovative HydroCoil® Embolic System for treating cerebral aneurysms reduced recurrence and retreatment rates and provided improved outcomes in study patients when compared to bare platinum coils, which are considered the standard...

2010-07-13 09:35:00

BOCA RATON, Fla., July 13 /PRNewswire-USNewswire/ -- W. Anthony Lee, MD, FACS, an internationally recognized endovascular specialist, has been recruited to serve as Director of the Endovascular Program at Boca Raton Community Hospital's Christine E. Lynn Heart and Vascular Institute. Dr. Lee's appointment was effective July 1, 2010. He has also joined Surgical Associates of Palm Beach County, one of the largest multi-specialty surgical practices in south Florida. Dr. Lee comes to Boca...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related